Rock Steady Boxing vs. Sensory Attention Focused Exercise

Parkinson Disease Clinical Trial

Official title:

A Randomized Crossover Trial: The Effects of Rock Steady Boxing vs. Sensory Attention Focused Exercise on Disease Progression for Those With Parkinson's Disease.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03618901
• Other study ID #: MDRC2
• Status: Recruiting
• Phase: N/A
• Start date: September 30, 2018
• Est. completion date: August 30, 2019

Study information

• Verified date: May 2019
• Source: Sun Life Financial Movement Disorders Research and Rehabilitation Centre
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the effect on Rock Steady Boxing (RSB) and PD SAFEx on Parkinson's disease.

Description:

Both interventions produce benefits to the PD population. PD SAFEx has been proven to improve the motor symptoms of PD. However, research still needs to be conducted on the PD specific benefits associated with RSB. As such it an RCT is necessary to compare the effects of both interventions.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: August 30, 2019
• Est. primary completion date: July 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• must be able to understand verbal instructions in English

• diagnosed with idiopathic PD by a neurologist

Exclusion Criteria:

• if diagnosed with a neurological condition other than PD

• if participated in an exercise program at least 2-weeks prior to the start of the study

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• Rock Steady Boxing
Boxing programs as offered by the Rock Steady Boxing institution,
• PD SAFEx
Progressive proprioception training.

Locations

Country	Name	City	State
Canada	Movement Disorders Research and Rehabilitation Centre	Waterloo	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Sun Life Financial Movement Disorders Research and Rehabilitation Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Balance3	Balance will be measured using the mini- Balance Evaluation Systems Test (mini-best test). There are 4 sections: anticipatory, (sub score 6) reactive postural control (sub score 6), sensory orientation (sub score 6), dynamic gait (sub score 10). The total score that can be achieved is 28. The higher the score the better the balance.	change from baseline at 12 weeks
Other	Physical activity	Community Healthy Activities Model Program for Seniors (CHAMPS) is a questionnaire used to assess the weekly frequency and duration of the physical activities of seniors.	change from baseline at 12 weeks
Other	Gait 2	For the 6-minute walking test (6MWT) participants will be asked to walk as far as possible for 6 minutes. The further (more laps) they are able to walk the better.	change from baseline at 12 weeks
Primary	Motor symptom improvements	Unified Parkinson Disease Rating Scale (UPDRS) conducted by a qualified movement disorders specialist. The maximum score is 108, the higher the score, the worse the symptoms.	change from baseline at 12 weeks
Secondary	Quality of life assessments	Completion of Parkinson's Disease Questionnaire (PDQ-39). There are 8 sections: mobility (sub score 10), activities of daily living (sub score 6), emotional well-being (sub score 6), stigma (sub score 4), social support (sub score 3), cognition (sub score 4), communication (sub score 3) and bodily discomfort (sub score 3). The higher the score, the worse the symptoms.	change from baseline at 12 weeks
Secondary	Balance1	Using the Biodex balance system. The postural stability test (PST) will be conducted. The results will be presented as actual score and standard deviation for both legs to determine an individuals ability to maintain balance. The lower the score the better.	change from baseline at 12 weeks
Secondary	Gait1	For the timed-up-and-go test (TUG) participants will stand up, walk to the line on the floor, turn around and walk back to the chair and sit down.	change from baseline at 12 weeks
Secondary	Strength	Will be assessed using the Jamar hand dynamometer.	change from baseline at 12 weeks
Secondary	Cognitive Assessment 1	Scale of Outcomes of Parkinson Disease (SCOPA-COG), will be used to assess memory and visuospatial function. There are 5 sections: memory learning, attention, executive functions, visuo-spatial functions and memory. The total score that can be achieved is 43 (the higher the score the better).	change from baseline at 12 weeks
Secondary	cognitive assessment 3	Completion of Montreal Cognitive Assessment (MoCA). There are a total 30 points, the higher the score the better (26 and above is normal).	change from baseline at 12 weeks
Secondary	Balance 2	Activities-specific Balance Confidence Scale (ABC). The total score that can be achieved is 16, the higher the percent the more self-confidence.	change from baseline at 12 weeks
Secondary	Cognitive assessment 2	Mini-Mental State Examination (MMSE). The total score than can be achieved is otal score 30 (the higher the score the better).	change from baseline at 12 weeks